LXU
name pending profile ingest
All ownership figures: tracked 13F managers only, common-stock positions, reporting period Q2 2024
| Quarter | Holders | Δ | Shares | Reported value | New | Exits |
|---|---|---|---|---|---|---|
| Q2 2026 | 77 | +6 | 33.21M | $359.15M | +12 | −7 |
| Q1 2026 | 74 | +8 | 33.32M | $496.66M | +11 | −3 |
| Q4 2025 | 66 | 0 | 25.28M | $214.87M | +1 | −1 |
| Q3 2025 | 16 | +1 | 14.81M | $116.69M | +1 | n/a |
| Q2 2025 | 12 | +1 | 13.91M | $108.52M | +2 | −1 |
| Q1 2025 | 8 | 0 | 4.86M | $32.06M | n/a | n/a |
| Q4 2024 | 8 | -1 | 5.05M | $38.32M | n/a | −1 |
| Q3 2024 | 8 | +1 | 3.81M | $30.64M | +1 | n/a |
| Q2 2024 | 7 | n/a | 3.96M | $32.42M | n/a | n/a |
| # | Manager | Shares | Δ shares | Value | Their weight | Held | ||
|---|---|---|---|---|---|---|---|---|
| 1 | Renaissance Technologies ✦ | 1.82M | n/a | $14.86M | 0.0% | n/c | 1 | SEC ↗ |
| 2 | Geode Capital Management ✦ (passive) | 1.33M | n/a | $10.91M | 0.0% | n/c | 1 | SEC ↗ ×2 |
| 3 | D. E. Shaw & Co. ✦ | 429.07K | n/a | $3.51M | 0.0% | n/c | 1 | SEC ↗ ×2 |
| 4 | Citadel Advisors ✦ | 194.87K | n/a | $1.59M | 0.0% | n/c | 1 | SEC ↗ |
| 5 | AQR Capital Management ✦ | 91.33K | n/a | $747,112 | 0.0% | n/c | 1 | SEC ↗ ×2 |
| 6 | Two Sigma Investments ✦ | 58.55K | n/a | $478,923 | 0.0% | n/c | 1 | SEC ↗ |
| 7 | T. Rowe Price ✦ | 38.78K | n/a | $318,000 | 0.0% | n/c | 1 | SEC ↗ |
“Their weight” = the position's share of that manager's reported 13F equity value: the conviction measure. ✦ = curated manager.
New buyers
| No new tracked buyers this quarter. |
Exited
| No tracked exits this quarter. |
Full-market context: across ALL 13F filers (SEC structured data, Q1 2026): 188 holders, 48.81M shares, $703.04M reported. This is a different, older period than the tracked-universe figures above and the two are never mixed.
What else this security's tracked holders most often hold: shared-ownership counts, not fundamental relationships.
Open-market purchases (P)
Director · 1.00K sh @ 11.30 · $11,300
Director · 1.00K sh @ 9.89 · $9,890
Open-market sales (S)
No open-market insider sales in our coverage window.
Awards, exercises and tax withholding are never counted as buys or sales here. Methodology